These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2034046)

  • 1. Barium sulfate suspension as a negative oral MRI contrast agent: in vitro and human optimization studies.
    Li KC; Tart RP; Fitzsimmons JR; Storm BL; Mao J; Rolfes RJ
    Magn Reson Imaging; 1991; 9(2):141-50. PubMed ID: 2034046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High density barium sulfate suspension for MRI: optimization of concentration for bowel opacification.
    Ballinger JR; Ros PR
    Magn Reson Imaging; 1992; 10(4):637-40. PubMed ID: 1501534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low density barium and bentonite mixture versus high density barium: a comparative study to optimize negative gastrointestinal contrast agents for MRI.
    Paley MR; Nicolas AI; Mergo PJ; Torres GM; Burton SS; Ros PR
    Magn Reson Imaging; 1997; 15(9):1033-6. PubMed ID: 9364949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR imaging of the gastrointestinal tract with i.v., gadolinium and diluted barium oral contrast media compared with unenhanced MR imaging and CT.
    Low RN; Francis IR
    AJR Am J Roentgenol; 1997 Oct; 169(4):1051-9. PubMed ID: 9308464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of barium as a gastrointestinal contrast agent in MR imaging: a comparison study in normal volunteers.
    Ros PR; Steinman RM; Torres GM; Burton SS; Panaccione JL; Rappaport DC; McGorray SP
    AJR Am J Roentgenol; 1991 Oct; 157(4):761-7. PubMed ID: 1892032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potentially artifact-free oral contrast agent for gastrointestinal MRI.
    Liebig T; Stoupis C; Ros PR; Ballinger JR; Briggs RW
    Magn Reson Med; 1993 Nov; 30(5):646-9. PubMed ID: 8259066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation of radiographically detectable gastrointestinal contrast agents for magnetic resonance imaging: effects of a barium sulfate additive on MR contrast agent effectiveness.
    Rubin DL; Muller HH; Young SW
    Magn Reson Med; 1992 Jan; 23(1):154-65. PubMed ID: 1734177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of oral contrast agents for abdominal magnetic resonance imaging.
    Kraus BB; Rappaport DC; Ros PR; Torres GM
    Magn Reson Imaging; 1994; 12(6):847-58. PubMed ID: 7968284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Two Neutral Oral Contrast Agents in Pediatric Patients: A Prospective Randomized Study.
    Dillman JR; Towbin AJ; Imbus R; Young J; Gates E; Trout AT
    Radiology; 2018 Jul; 288(1):245-251. PubMed ID: 29737955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of a negative oral contrast agent for magnetic resonance imaging.
    Davis MA; Mei H; Ritsema GH
    Invest Radiol; 1994 Jun; 29 Suppl 2():S120-2. PubMed ID: 7928205
    [No Abstract]   [Full Text] [Related]  

  • 11. An aqueous gastrointestinal contrast agent for use in echo-planar MR imaging.
    Hahn PF; Saini S; Cohen MS; Goldberg M; Reimer P; Mueller PR
    Magn Reson Med; 1992 Jun; 25(2):380-3. PubMed ID: 1614323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High density barium sulphate as an MRI oral contrast.
    Marti-Bonmati L; Vilar J; Paniagua JC; Talens A
    Magn Reson Imaging; 1991; 9(2):259-61. PubMed ID: 2034060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Patient Tolerance and Small-Bowel Distention With a New Small-Bowel Distending Agent for Enterography.
    Kolbe AB; Fletcher JG; Froemming AT; Sheedy SP; Koo CW; Pundi K; Bruining DH; Tung J; Harmsen WS; Barlow JM; Fidler JL
    AJR Am J Roentgenol; 2016 May; 206(5):994-1002. PubMed ID: 26998661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rectal barium in pelvic MR imaging: initial results.
    Panaccione JL; Ros PR; Torres GM; Burton SS
    J Magn Reson Imaging; 1991; 1(5):605-7. PubMed ID: 1790387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of a low-cost negative contrast agent: a three-year experience in routine practice.
    Ernst O; Sergent G; L'Hermine C
    J Magn Reson Imaging; 1997; 7(3):495-8. PubMed ID: 9170033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3T MR of the prostate: reducing susceptibility gradients by inflating the endorectal coil with a barium sulfate suspension.
    Rosen Y; Bloch BN; Lenkinski RE; Greenman RL; Marquis RP; Rofsky NM
    Magn Reson Med; 2007 May; 57(5):898-904. PubMed ID: 17457870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteric MRI contrast agents: comparative study of five potential agents in humans.
    Tart RP; Li KC; Storm BL; Rolfes RJ; Ang PG
    Magn Reson Imaging; 1991; 9(4):559-68. PubMed ID: 1779727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barium sulfate products for roentgenographic examination of the gastrointestinal tract.
    McKee MW; Jurgens RW
    Am J Hosp Pharm; 1986 Jan; 43(1):145-8. PubMed ID: 3953584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barium suspension formulation for use with the bubbly barium method.
    de Lange EE; Shaffer HA
    Radiology; 1985 Mar; 154(3):825. PubMed ID: 3969489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms that contribute to the in vitro relaxation and signal intensity of water in barium sulfate suspensions used as MRI contrast agents.
    Briggs RW; Liebig T; Ballinger JR; Ros PR
    Magn Reson Imaging; 1993; 11(5):635-44. PubMed ID: 8345778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.